Trial site
Asheville Clinical Research
Asheville, North Carolina 28803, United StatesNot linked to an institution yet
- 7running trials
- 3closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Phase
- Phase 36 trials
- Phase 24 trials
- Status
- Recruiting4 trials
- Active, not recruiting3 trials
- Completed3 trials
- Lead sponsor
- Viridian Therapeutics, Inc.2 trials
- Amgen1 trial
- argenx1 trial
- Biogen1 trial
- Diasome Pharmaceuticals1 trial
- and 4 more
Running trials
Recruiting
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
NCT07722546· Phase 2· Biogen· Source
Contact: Lauren Bernstein (principal investigator)
Recruiting
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
NCT07570316· Phase 3· argenx· Source
Contact: Lauren Bernstein
Recruiting
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
NCT07187531· Phase 2· SAb Biotherapeutics, Inc.· Source
Contact: Jyothsna Paleti
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
NCT07231419· Phase 3· Vertex Pharmaceuticals Incorporated· Source
Active, not recruiting
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight
NCT06858878· Phase 3· Amgen· Source
Active, not recruiting
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)
NCT06625398· Phase 3· Viridian Therapeutics, Inc.· Source
Active, not recruiting
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)
NCT06625411· Phase 3· Viridian Therapeutics, Inc.· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error